Reaction

Pulmonary Valve Incompetence reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,412 reports · 26 co-occurring drugs

As of the last recalculation, Pulmonary Valve Incompetence appears in 1,412 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is CAPTOPRIL (PRR 26.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Captopril1726.426.4
Clobazam3924.224.2
Felodipine Extended-Release Tablets1620.921.0
Felodipine1620.921.0
Digoxin9119.919.9
Brivaracetam1219.819.9
Atropine1017.917.9
Chlorhexidine Gluconate1117.917.9
Etonogestrel And Ethinyl Estradiol2516.916.9
Asenapine Maleate915.415.4
Enalapril Maleate2313.913.9
Atropine Sulfate1013.713.7
Cannabidiol2113.413.4
Nebivolol1413.113.1
Cenobamate712.412.4
Paroxetine Hydrochloride7312.412.4
Aripiprazole Oral3312.012.0
Aripiprazole Orally Disintegrating3312.012.0
Metolazone911.911.9
Amiodarone Hydrochloride810.610.6
Clozapine8110.010.0
Daptomycin69.69.6
Midazolam169.59.5
Paliperidone127.67.6
Tafamidis56.36.3
Hydrocodone Bitartrate113.83.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.